Paraneoplastic sensorimotor neuropathy, neural autoantibody negative (Q100992): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed label, description and/or aliases in pt-br, en
description / pt-brdescription / pt-br
 
A neuropatia sensitivo motora paraneoplásica ocorre como um efeito remoto em pacientes com câncer e linfoma em uma frequência indeterminada. É uma neuropatia sensitivo motora atípica com componentes motores e sensoriais mistos, também com uma grande variação de expressão clínica. A neuropatia pode ocorrer na primeira apresentação do câncer, ou aparecer no curso tardio, onde deve ser diferenciada da toxicidade do tratamento, sequelas de perda de peso e hipovitaminose. Anticorpo negativo.
description / endescription / en
 
Paraneoplastic sensorimotor neuropathy occurs as a remote effect in cancer and lymphoma patients in an undetermined frequency. It is an uncharacteristic sensorimotor neuropathy with mixed motor and sensory component also with a large variance of clinical expression. The neuropathy can occur at the first presentation of the cancer, or appear in the later course, where it has to be distinguished from treatment toxicity, sequelae of weight loss and hypovitaminosis. Antibody negative.

Revision as of 17:46, 16 August 2026

Paraneoplastic sensorimotor neuropathy occurs as a remote effect in cancer and lymphoma patients in an undetermined frequency. It is an uncharacteristic sensorimotor neuropathy with mixed motor and sensory component also with a large variance of clinical expression. The neuropathy can occur at the first presentation of the cancer, or appear in the later course, where it has to be distinguished from treatment toxicity, sequelae of weight loss and hypovitaminosis. Antibody negative.
Language Label Description Also known as
default for all languages
ID_1966156686
    English
    Paraneoplastic sensorimotor neuropathy, neural autoantibody negative
    Paraneoplastic sensorimotor neuropathy occurs as a remote effect in cancer and lymphoma patients in an undetermined frequency. It is an uncharacteristic sensorimotor neuropathy with mixed motor and sensory component also with a large variance of clinical expression. The neuropathy can occur at the first presentation of the cancer, or appear in the later course, where it has to be distinguished from treatment toxicity, sequelae of weight loss and hypovitaminosis. Antibody negative.

      Statements